CLINICAL TRIALS AND OBSERVATIONS Brief report Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trial
نویسندگان
چکیده
Brief report Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trial Philippe Moreau,1 Michel Attal,2 Brigitte Pégourié,3 Lucie Planche,1 Cyrille Hulin,4 Thierry Facon,5 Anne-Marie Stoppa,6 Jean-Gabriel Fuzibet,7 Bernard Grosbois,8 Chantal Doyen,9 Nicolas Ketterer,10 Catherine Sebban,11 Brigitte Kolb,12 Carine Chaleteix,13 Mamoun Dib,14 Laurent Voillat,15 Jean Fontan,16 Laurent Garderet,17 Jérôme Jaubert,18 Claire Mathiot,19 Dixie Esseltine,20 Hervé Avet-Loiseau,1 and Jean-Luc Harousseau,21 for the IFM 2005-01 study investigators*
منابع مشابه
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network
Mantle-cell lymphoma (MCL) is characterized by poor prognosis with a median survival of only 3 to 4 years. To improve clinical outcome, the European MCL Network initiated a randomized trial comparing consolidation with myeloablative radiochemotherapy followed by autologous stem cell transplantation (ASCT) to interferon maintenance (IFN ) in first remission. Patients 65 years of age or younger w...
متن کاملCLINICAL TRIALS AND OBSERVATIONS Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993
The international acute lymphoblastic leukemia (ALL) study was designed to prospectively define the optimal therapy for adults 60 years of age or younger with newly diagnosed ALL. All patients received identical induction therapy, and 91% achieved complete remission (CR). Patients 50 years of age or younger with a compatible sibling were assigned to undergo allogeneic transplantation; the other...
متن کاملCLINICAL TRIALS AND OBSERVATIONS FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma
Risk-adapted lymphoma treatment requires early and accurate assessment of prognosis. This investigation prospectively assessed the value of positron emission tomography with 2-[18F]fluoro-2-deoxy-Dglucose (FDG-PET) after two cycles of chemotherapy for prediction of progressionfree survival (PFS) and overall survival (OS) in Hodgkin lymphoma (HL). Seventy-seven consecutive, newly diagnosed patie...
متن کاملCLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma
Second-line chemotherapy followed by high-dose therapy (HDT) with autologous stem cell transplantation (ASCT) cures less than half of the patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). Prognostic models capable of predicting outcome are essential. In 3 sequential clinical trials, conducted from January 1993 to August 2000, we treated 150 patients with relapsed or pr...
متن کاملCLINICAL TRIALS AND OBSERVATIONS Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations
To assess the prognostic relevance of mutations in the NPM1 gene encoding a nucleocytoplasmic shuttle protein in younger adults with acute myeloid leukemia (AML) and normal cytogenetics, sequencing of NPM1 exon 12 was performed in diagnostic samples from 300 patients entered into 2 consecutive multicenter trials of the AML Study Group (AMLSG). Treatment included intensive double-induction thera...
متن کامل